Javier Cortes, José Baselga. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh: See more » AnastrozoleAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Hormonal/administration & dosageAntineoplastic Agents, Hormonal/adverse effectsAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsBiomarkers, Tumor/analysisBiomarkers, Tumor/geneticsBreast Neoplasms/drug therapyBreast Neoplasms/geneticsBreast Neoplasms/mortalityDisease-Free SurvivalDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansLapatinibNitriles/administration & dosageNitriles/adverse effectsPrognosisQuinazolines/adverse effectsQuinazolines/therapeutic useRandomized Controlled Trials as TopicReceptor, ErbB-2/geneticsReceptor, ErbB-2/metabolismReceptors, Estrogen/geneticsReceptors, Estrogen/metabolismRisk AssessmentSurvival AnalysisTime FactorsTrastuzumabTriazoles/administration & dosageTriazoles/adverse effects
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic Agents, HormonalBiomarkers, TumorNitrilesQuinazolinesReceptors, EstrogenTriazolesLapatinibAnastrozoleReceptor, ErbB-2Trastuzumab
Year: 2009 PMID: 19786653 DOI: 10.1200/JCO.2009.23.8089
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544